Namb Pharmaceuticals Private Limited
About Namb Pharmaceuticals Private Limited
Data last updated:
Namb Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It was incorporated on 02 May 2023.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U86100UT2023PTC015576.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Bansi Devi and Basant Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dehradun, Uttarakhand.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.38 Lakh. For the same year it recorded a net profit of ₹7,168 (net margin 0.5%) and EBITDA of ₹8,508 (EBITDA margin 0.6%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Rishi Raj Shukla, Inderlok Colony Haridw, Dehradun, Uttarakhand, India – 248171
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Namb Pharmaceuticals Private Limited
The main business activity of Namb Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Namb Pharmaceuticals Private Limited FY 2025 filings available
Namb Pharmaceuticals Private Limited reported revenue of ₹14.38 Lakh for FY 2025.
Financial Statement Summary of Namb Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹8,508 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹7,168 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Namb Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.6% | •••• |
| Net Profit Margin | 0.5% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Namb Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Namb Pharmaceuticals Private Limited
Namb Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Bansi Devi | Director | 02 May 2023 | 3 Years 5 Months | Current |
| Basant Kumar | Director | 02 May 2023 | 3 Years 5 Months | Current |
Peer Comparison of Namb Pharmaceuticals Private Limited
Namb Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acculife Pharmaceuticals Private Limited | ₹14.42 Lakh (FY 2024) | •••• | •••• | 17.0% | •••• | Jalna, Maharashtra, India |
| Elinza Pharmaceuticals Private Limited | ₹14.42 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Chandigarh, India |
| Great Bear Pharmaceuticals Private Limited | ₹14.41 Lakh (FY 2022) | •••• | •••• | •••• | Hajipur, Bihar, India | |
| Aspiris Pharmaceuticals Private Limited | ₹14.4 Lakh (FY 2024) | •••• | •••• | 175.0% | •••• | Delhi, India |
| Orvietan Pharmaceuticals Private Limited | ₹14.38 Lakh (FY 2024) | •••• | •••• | -25.0% | •••• | Hyderabad, Telangana, India |
| Namb Pharmaceuticals Private Limited this company | ₹14.38 Lakh (FY 2025) | •••• | •••• | •••• | Dehradun, Uttarakhand, India | |
| Sushain Pharmaceuticals Private Limited | ₹14.37 Lakh (FY 2020) | •••• | •••• | -35.0% | •••• | Bareilly, Uttar Pradesh, India |
| Nyg Pharmaceuticals Private Limited | ₹14.34 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | New Delhi, Delhi, India |
| Pushpansh Pharmaceuticals Limited | ₹14.31 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Allahabad, Uttar Pradesh, India |
| Bij Care Pharmaceuticals Private Limited | ₹14.3 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Manda, Maharashtra, India |
| Twinwin Pharmaceuticals India Private Limited | ₹14.3 Lakh (FY 2025) | •••• | •••• | •••• | Tumkur, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Namb Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Namb Pharmaceuticals Private Limited
Namb Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Namb Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Namb Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Namb Pharmaceuticals Private Limited
Namb Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Basant Kumar was appointed as Director on 02 May 2023.
Credit Ratings, Litigation & Regulatory Alerts for Namb Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Namb Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Namb Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Namb Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Namb Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Namb Pharmaceuticals Private Limited
Namb Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. It was incorporated on 02 May 2023 (3+ years old) and is registered under CIN U86100UT2023PTC015576.
Namb Pharmaceuticals reported revenue of ₹14.38 Lakh for FY 2025.
Namb Pharmaceuticals has 2 current directors:
- Raj Bansi Devi - Director
- Basant Kumar - Director
Namb Pharmaceuticals reported a net profit of ₹7,168 (net margin 0.5%) and EBITDA of ₹8,508 (EBITDA margin 0.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Namb Pharmaceuticals is U86100UT2023PTC015576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Namb Pharmaceuticals was incorporated on 02 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Namb Pharmaceuticals by revenue are Acculife Pharmaceuticals Private Limited, Elinza Pharmaceuticals Private Limited, Great Bear Pharmaceuticals Private Limited, Aspiris Pharmaceuticals Private Limited, Orvietan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Basant Kumar was appointed as Director on 02 May 2023. Raj Bansi Devi was appointed as Director on 02 May 2023.
The registered office of Namb Pharmaceuticals is at CO Rishi Raj Shukla, Inderlok Colony Haridw, Dehradun, Uttarakhand, India – 248171.
Namb Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
No. Namb Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.